Article Information
History
- July 6, 2021.
Article Versions
- You are currently viewing Version 1 of this article (July 6, 2021 - 11:06).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rebecca Cordery1,
- Amrit Purba1,
- Lipi Begum1,
- Ewurabena Mills2,
- Mia Mosavie2,3,
- Ana Vieira2,3,4,
- Elita Jauneikaite3,4,5,
- Rhoda CY Leung2,
- Derren Ready6,7,
- Peter Hoffman6,
- Theresa Lamagni3,6 and
- Shiranee Sriskandan2,3,4,*
- 1London Health Protection Teams, Public Health England, London, United Kingdom
- 2Department of Infectious Disease, Imperial College London, United Kingdom
- 3NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, United Kingdom
- 4MRC Centre for Molecular Bacteriology & Infection, Imperial College London, United Kingdom
- 5Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, United Kingdom
- 6National Infection Service, Public Health England, United Kingdom
- 7NIHR Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol, Bristol, UK
- ↵*Author for correspondence: Shiranee Sriskandan, Section of Adult Infectious Disease, Department of Infectious Disease, Imperial College London, Hammersmith Campus, London W12 0NN, UK Email: s.sriskandan{at}imperial.ac.uk